Your browser doesn't support javascript.
loading
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
Tod, M; Lortholary, O; Seytre, D; Semaoun, R; Uzzan, B; Guillevin, L; Casassus, P; Petitjean, O.
Affiliation
  • Tod M; Hôpital Avicenne, and Centre de Recherche en Pathologie Infectieuse et Tropicale 93, UFR de Médecine Paris-Nord, Bobigny, France. michel.tod@ave.ap-hop-paris.fr
Antimicrob Agents Chemother ; 42(4): 849-56, 1998 Apr.
Article in En | MEDLINE | ID: mdl-9559795
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Fever / Anti-Bacterial Agents / Neutropenia Type of study: Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 1998 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Fever / Anti-Bacterial Agents / Neutropenia Type of study: Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 1998 Document type: Article Affiliation country: France Country of publication: United States